表紙
市場調査レポート

世界の動物用ワクチン市場:動物疾患、技術、動物、地域別 - 動向および予測

Global Veterinary Vaccines Market Segmented By Veterinary Diseases , By Technology, By Animal Type & By Geography - Trends And Forecast 2015-2020

発行 Mordor Intelligence LLP 商品コード 319396
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.39円で換算しております。
Back to Top
世界の動物用ワクチン市場:動物疾患、技術、動物、地域別 - 動向および予測 Global Veterinary Vaccines Market Segmented By Veterinary Diseases , By Technology, By Animal Type & By Geography - Trends And Forecast 2015-2020
出版日: 2016年01月01日 ページ情報: 英文
概要

世界の動物用ワクチン市場は2014年に120億米ドルとなる見込みです。同市場は今後もCAGR8.8%で拡大し、2019年には190億米ドルに達するとみられています。家畜やコンパニオンアニマルの増加、動物の慢性疾患の発症率上昇などが、より良い動物医療のニーズを促進しています。

当レポートでは、世界の動物用ワクチン市場の動向と将来予測、市場に参入する主要企業の競合環境、市場シェア、近年の動向とともにプロファイルをまとめています。

第1章 イントロダクション

第2章 市場分析

  • 動物医療製品市場
  • 動物医療とヒトの医療

第3章 市場動向

  • 市場促進因子
    • ペット所有率の上昇
    • 栄養の改善
    • 食品安全に対する消費者の意識向上
    • 家畜生産の増大
    • 人畜共通感染症、食品媒介疾患
  • 市場阻害因子
    • 耕作地と水の不足
    • 耕地に関する競争激化
    • 費用対効果の高い生産
  • ポーターズファイブフォース分析

第4章 世界の動物用ワクチン市場セグメンテーション:動物別、疾患別

  • コンパニオンアニマル
  • 鶏ワクチン市場:疾患別
  • 豚ワクチン市場:疾患別
  • 馬ワクチン市場:疾患別
  • 世界の動物用ワクチン市場:技術別
    • トキソイドワクチン
    • 組換えワクチン
    • 不活化ワクチン
    • 弱毒化生ワクチン
  • 世界の動物用ワクチン市場:地域別
    • 北米
    • 欧州
    • アジア太平洋地域

第5章 競合環境

  • 市場における主要参入企業
  • 合併・買収
  • 新製品上市
  • 協定、連携、提携

第6章 企業プロファイル

  • Zoetis animal healthcare
  • Merck
  • Merial (Animal Health Division Of Sanofi)
  • Elanco
  • Bayer healthcare
  • Novartis Animal Health, Inc.
  • Virbac
  • Boehringer Ingelheim

第7章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

The Global market for Veterinary Vaccines has been estimated at USD 12.12 billion in 2015and is projected to reach USD 20.81 billion by 2020at a CAGR of 9.42% during the forecast period from 2015 to 2020. Veterinary vaccines help to improve health and welfare of animals, increase production of livestock in a cost effective manner and prevent transmission of diseases among animals and also to humans. Efficient animal production and better access to high-quality protein dramatically increase meat and egg production and contribute to greater economic outcome. Also, rapid development of animal vaccines can play an effective role in controlling emerging diseases. Veterinary vaccines comprise only approximately 23% of the global market for animal health products.

Key factors like technological innovations, growing awareness of animal health, increasing investmentsby government bodies and associations are driving the market growth. In addition, increased demand for animal protein, including milk, meat, eggs and fish, increased expenditure on healthcare of companion animals.However, rising maintenance costs for storage of vaccines, increasing adoption of vegetarian food in major economies owing to increasing risk of obesity and other chronic disorders, persistent economic slowdown are key factors limiting the growth of this market.

The veterinary vaccines market is segmented on the basis of products, diseases, technologies and regions. Based on product type, the market is categorized into companion animal vaccines, livestock vaccines, poultry vaccines, porcine vaccines, equine vaccines, aquaculture vaccines and other animal vaccines. Porcine vaccines is the largest sub-segment contributing to major share of the market, whereas companion animal Vaccines is the fastest growing segment due to increasing prevalence of zoonotic diseases in humans and growing pet population. The technology segment includes live attenuated, inactivated, subunit, conjugate, toxoid, recombinant and DNA vaccines. Live attenuated vaccine technology is the major technology in the veterinary vaccines market. The disease type segment includes Rabies, Brucellosis, Leptospirosis, Influenza, Rift Valley fever, Newcastle disease, Nipah virus infection, Hendra virus infection, Porcine Reproductive and Respiratory Syndrome virus and Japanese encephalitis Q fever.

Based on geography, the market is segmented into North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW). European region is the leading veterinary vaccine market closely followed by United States. Middle East, Brazil, Argentina, Mexico, Turkey, China, and India are lucrative markets for veterinary vaccines, owing to growing demand for livestock, development of new products and favorable government initiatives.

Pfizer Animal Health, Merck Animal Health, Sanofi-Aventis Animal Health, Bayer Healthcare - Animal Health, Virbac, Novartis Animal Health, BoehringerIngelheim Animal Health and Heska Corporation are few of the key players for this market. The top 3 players in the Veterinary Vaccines market are Pfizer, Merck and Sanofi-Aventis, based on the revenues they generate each year. Pfizer is the market leader in the Veterinary vaccines market (by revenue) but Merck is the market leader in Livestock Vaccines market and Sanofi-Aventis is leading in the Companion Vaccines market. There have few Mergers/Acquisitions by the key players in the Veterinary Vaccines market to expand their product portfolio in order to top the global market. Ex: Pfizer acquiring Wyeth which supposedly the largest acquisition. The industry players have adopted certain growth strategies to excel in veterinary vaccines

Table of Contents

INTRODUCTION

  • Study deliveratives
  • Market Definition
  • Sizing Units
  • Base Currency
  • Review and forecasr period years
  • General Study Assumptions

RESEARCH METHODOLOGY

  • Introduction
  • Analysis Methodology
  • Econometric forecast models
  • Research Assumptions

EXECUTIVE SUMMARY

KEY INFERENCES

MARKET OVERVIEW AND INDUSTRY TRENDS

  • Current market scenario
  • Technology Overview
  • New developments in therapeutics
  • Investment analysis
  • Porters Five Force Analysis
  • Bargaining Power of suppliers
  • Bargaining power of buyers
  • Degree of competition
  • Threat of substitution
  • Threat of new entrants

DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)

  • Market Drivers
  • Increase in pet ownership
  • Improved Nutrition
  • Intensifying consumer focus on food safety
  • Greater Livestock production
  • Increasing Zoonotic and Foodborne Diseases
  • Market Restraints
  • Scarcity of arable land and water
  • Increased competition for cultivated land
  • Cost effective production
  • Market Opportunities
  • Key Challenges
  • Global veterinary vaccine market Segmentation, By Type of Animals,based on diseases
  • Companion Animals
  • Disease mainly transferred by Saliva through Bites and Scratch
  • Capnocytophaga canimorsus
  • Pasteurella multocida
  • Cat scratch disease
  • Rabies
  • Enteric diseases with mainly faecal-oral transmittance
  • Salmonellosis
  • Camphylobacteriosis
  • Toxocarosis
  • Protozoans
  • Respiratory Tract Diseases
  • BRSV
  • Enzootic Bronchopneu
  • EVPC
  • IBR
  • Gastrointestinal Diseases
  • BVD/MD
  • Leptospirosis
  • Poultry Vaccines market , By diseases
  • Bronchitis
  • Avian Influenza
  • Marek's Disease
  • Newcastle Disease
  • Pig vaccines market, By disease
  • Porcine reproductive disease
  • Swine Influenza
  • Swine Pneumonia
  • Equine Vaccines market , By Disease
  • Encephalomyelitis
  • Rhinopneumonitis
  • Influenza (Horse Flu)
  • By Technology
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Inactivated Vaccines
  • Live Attenuated Vaccines (LAV)
  • Global veterinary vaccines market Segmentation, By Geography
  • Farm Animal Healthcare Market Financial Analytics Market, By Geography
  • North America
  • USA
  • Canada
  • Mexico
  • Europe
  • France
  • UK
  • Germany
  • Italy
  • Spain and Portugal
  • Scandinavia
  • BENELUX
  • Asia-Pacific
  • India
  • China
  • Japan
  • South Korea
  • Australia and New Zealand
  • Rest of Asia Pacific
  • Middle East and Africa
  • GCC
  • Egypt
  • Morocco
  • Algeria
  • South Africa
  • Rest of Middle East and Africa
  • Latin America
  • Brazil
  • Argentina
  • Rest of Latin America

COMPETITIVE LANDSCAPE

  • Mergers & Acquisitions
  • New Product Launches
  • Agreements, Collaborations & Partnerships

KEY VENDORS

  • Zoetis animal healthcare
  • Merck
  • Merial (Animal Health Division Of Sanofi)
  • Elanco
  • Bayer healthcare
  • Ceva Animal Health, Inc.
  • Virbac
  • Boehringer Ingelheim
  • Analyst outlook for Investment Opportunities
  • Future outlook of market

Appendix

  • Abbreviations
  • Bibliography
  • Disclaimer
Back to Top